Sigourney Bonner
Www.twitter.com
0000-0002-2912-3659
2 papers found
Refreshing results…
Black in Cancer: Two Years of Empowering the Next Generation
AZD0364 Is a Potent and Selective ERK1/2 Inhibitor That Enhances Antitumor Activity in KRAS-Mutant Tumor Models when Combined with the MEK Inhibitor, Selumetinib
Missing publications? Search for publications with a matching author name.